nodes	percent_of_prediction	percent_of_DWPC	metapath
Ruxolitinib—Plasmacytoma—Pamidronate—Paget's disease of bone	0.0537	0.099	CcSEcCtD
Ruxolitinib—Plasma cell myeloma—Pamidronate—Paget's disease of bone	0.0537	0.099	CcSEcCtD
Ruxolitinib—Plasma cell myeloma—Zoledronate—Paget's disease of bone	0.0491	0.0904	CcSEcCtD
Ruxolitinib—Plasmacytoma—Zoledronate—Paget's disease of bone	0.0491	0.0904	CcSEcCtD
Ruxolitinib—Prostate cancer—Zoledronate—Paget's disease of bone	0.0295	0.0543	CcSEcCtD
Ruxolitinib—Bone pain—Tiludronate—Paget's disease of bone	0.0208	0.0383	CcSEcCtD
Ruxolitinib—Night sweats—Zoledronate—Paget's disease of bone	0.0105	0.0193	CcSEcCtD
Ruxolitinib—Bone pain—Etidronic acid—Paget's disease of bone	0.00995	0.0183	CcSEcCtD
Ruxolitinib—Herpes zoster—Risedronate—Paget's disease of bone	0.00865	0.0159	CcSEcCtD
Ruxolitinib—Herpes zoster—Pamidronate—Paget's disease of bone	0.00822	0.0151	CcSEcCtD
Ruxolitinib—Contusion—Risedronate—Paget's disease of bone	0.00747	0.0138	CcSEcCtD
Ruxolitinib—Hypercholesterolaemia—Risedronate—Paget's disease of bone	0.00689	0.0127	CcSEcCtD
Ruxolitinib—Bone pain—Risedronate—Paget's disease of bone	0.0068	0.0125	CcSEcCtD
Ruxolitinib—Bone pain—Pamidronate—Paget's disease of bone	0.00646	0.0119	CcSEcCtD
Ruxolitinib—Bone pain—Zoledronate—Paget's disease of bone	0.00591	0.0109	CcSEcCtD
Ruxolitinib—Pancytopenia—Etidronic acid—Paget's disease of bone	0.00568	0.0105	CcSEcCtD
Ruxolitinib—Asthenia—Tiludronate—Paget's disease of bone	0.00509	0.00938	CcSEcCtD
Ruxolitinib—Dizziness—Tiludronate—Paget's disease of bone	0.00469	0.00864	CcSEcCtD
Ruxolitinib—Gastrointestinal haemorrhage—Pamidronate—Paget's disease of bone	0.0045	0.00828	CcSEcCtD
Ruxolitinib—Headache—Tiludronate—Paget's disease of bone	0.00445	0.00819	CcSEcCtD
Ruxolitinib—Flatulence—Etidronic acid—Paget's disease of bone	0.0041	0.00756	CcSEcCtD
Ruxolitinib—Haemoglobin—Alendronate—Paget's disease of bone	0.0041	0.00755	CcSEcCtD
Ruxolitinib—Haemorrhage—Alendronate—Paget's disease of bone	0.00408	0.00751	CcSEcCtD
Ruxolitinib—Anaemia—Etidronic acid—Paget's disease of bone	0.00385	0.00709	CcSEcCtD
Ruxolitinib—Infestation—Risedronate—Paget's disease of bone	0.00364	0.00671	CcSEcCtD
Ruxolitinib—Infestation NOS—Risedronate—Paget's disease of bone	0.00364	0.00671	CcSEcCtD
Ruxolitinib—Neutropenia—Pamidronate—Paget's disease of bone	0.00363	0.00669	CcSEcCtD
Ruxolitinib—Urinary tract infection—Risedronate—Paget's disease of bone	0.00354	0.00652	CcSEcCtD
Ruxolitinib—Flatulence—Alendronate—Paget's disease of bone	0.0035	0.00644	CcSEcCtD
Ruxolitinib—Infestation NOS—Pamidronate—Paget's disease of bone	0.00346	0.00638	CcSEcCtD
Ruxolitinib—Infestation—Pamidronate—Paget's disease of bone	0.00346	0.00638	CcSEcCtD
Ruxolitinib—Hepatobiliary disease—Risedronate—Paget's disease of bone	0.00345	0.00635	CcSEcCtD
Ruxolitinib—Infection—Etidronic acid—Paget's disease of bone	0.00338	0.00622	CcSEcCtD
Ruxolitinib—Pancytopenia—Zoledronate—Paget's disease of bone	0.00337	0.00621	CcSEcCtD
Ruxolitinib—Urinary tract infection—Pamidronate—Paget's disease of bone	0.00337	0.0062	CcSEcCtD
Ruxolitinib—Neutropenia—Zoledronate—Paget's disease of bone	0.00332	0.00611	CcSEcCtD
Ruxolitinib—Haematuria—Pamidronate—Paget's disease of bone	0.0033	0.00608	CcSEcCtD
Ruxolitinib—Haemoglobin—Risedronate—Paget's disease of bone	0.00329	0.00606	CcSEcCtD
Ruxolitinib—Anaemia—Alendronate—Paget's disease of bone	0.00328	0.00604	CcSEcCtD
Ruxolitinib—Haemorrhage—Risedronate—Paget's disease of bone	0.00327	0.00603	CcSEcCtD
Ruxolitinib—Weight increased—Zoledronate—Paget's disease of bone	0.00323	0.00595	CcSEcCtD
Ruxolitinib—Weight decreased—Zoledronate—Paget's disease of bone	0.00321	0.00591	CcSEcCtD
Ruxolitinib—Infestation—Zoledronate—Paget's disease of bone	0.00316	0.00583	CcSEcCtD
Ruxolitinib—Infestation NOS—Zoledronate—Paget's disease of bone	0.00316	0.00583	CcSEcCtD
Ruxolitinib—Haemoglobin—Pamidronate—Paget's disease of bone	0.00313	0.00576	CcSEcCtD
Ruxolitinib—Haemorrhage—Pamidronate—Paget's disease of bone	0.00311	0.00573	CcSEcCtD
Ruxolitinib—Urinary tract infection—Zoledronate—Paget's disease of bone	0.00308	0.00566	CcSEcCtD
Ruxolitinib—IRAK1—IL1-mediated signaling events—SQSTM1—Paget's disease of bone	0.00303	0.00662	CbGpPWpGaD
Ruxolitinib—Haematuria—Zoledronate—Paget's disease of bone	0.00302	0.00556	CcSEcCtD
Ruxolitinib—JAK2—IL3-mediated signaling events—INPP5D—Paget's disease of bone	0.00299	0.00653	CbGpPWpGaD
Ruxolitinib—BMPR2—Integrated Breast Cancer Pathway—PML—Paget's disease of bone	0.00296	0.00648	CbGpPWpGaD
Ruxolitinib—JAK1—Antiviral mechanism by IFN-stimulated genes—NUP205—Paget's disease of bone	0.00292	0.00639	CbGpPWpGaD
Ruxolitinib—JAK2—Interleukin receptor SHC signaling—INPP5D—Paget's disease of bone	0.0029	0.00635	CbGpPWpGaD
Ruxolitinib—ROCK1—AGE/RAGE pathway—ALPL—Paget's disease of bone	0.00289	0.00633	CbGpPWpGaD
Ruxolitinib—Infection—Alendronate—Paget's disease of bone	0.00288	0.0053	CcSEcCtD
Ruxolitinib—MAP3K7—IL1-mediated signaling events—SQSTM1—Paget's disease of bone	0.00285	0.00623	CbGpPWpGaD
Ruxolitinib—Malnutrition—Risedronate—Paget's disease of bone	0.00285	0.00524	CcSEcCtD
Ruxolitinib—Flatulence—Risedronate—Paget's disease of bone	0.00281	0.00517	CcSEcCtD
Ruxolitinib—TYK2—Interleukin-11 Signaling Pathway—BGLAP—Paget's disease of bone	0.00278	0.00608	CbGpPWpGaD
Ruxolitinib—PRKG2—Circadian rythm related genes—PML—Paget's disease of bone	0.00277	0.00606	CbGpPWpGaD
Ruxolitinib—JAK1—IL4-mediated signaling events—INPP5D—Paget's disease of bone	0.00274	0.00601	CbGpPWpGaD
Ruxolitinib—MAP3K7—Downstream TCR signaling—INPP5D—Paget's disease of bone	0.00274	0.00599	CbGpPWpGaD
Ruxolitinib—Malnutrition—Pamidronate—Paget's disease of bone	0.00271	0.00499	CcSEcCtD
Ruxolitinib—IRAK1—Interleukin-1 signaling—SQSTM1—Paget's disease of bone	0.00266	0.00581	CbGpPWpGaD
Ruxolitinib—Anaemia—Risedronate—Paget's disease of bone	0.00263	0.00485	CcSEcCtD
Ruxolitinib—JAK1—Interferon gamma signaling—PML—Paget's disease of bone	0.00261	0.00571	CbGpPWpGaD
Ruxolitinib—JAK2—EPO signaling pathway—INPP5D—Paget's disease of bone	0.00261	0.0057	CbGpPWpGaD
Ruxolitinib—PLK1—Mitotic Prophase—NUP205—Paget's disease of bone	0.0026	0.00568	CbGpPWpGaD
Ruxolitinib—TYK2—Interleukin-2 signaling—INPP5D—Paget's disease of bone	0.00253	0.00553	CbGpPWpGaD
Ruxolitinib—MAP3K7—RANKL/RANK Signaling Pathway—TNFRSF11B—Paget's disease of bone	0.00252	0.0055	CbGpPWpGaD
Ruxolitinib—Anaemia—Pamidronate—Paget's disease of bone	0.0025	0.00461	CcSEcCtD
Ruxolitinib—MAP3K7—Interleukin-1 signaling—SQSTM1—Paget's disease of bone	0.0025	0.00547	CbGpPWpGaD
Ruxolitinib—Malnutrition—Zoledronate—Paget's disease of bone	0.00247	0.00455	CcSEcCtD
Ruxolitinib—Unspecified disorder of skin and subcutaneous tissue—Risedronate—Paget's disease of bone	0.00241	0.00443	CcSEcCtD
Ruxolitinib—Pruritus—Etidronic acid—Paget's disease of bone	0.00241	0.00443	CcSEcCtD
Ruxolitinib—DYRK1A—Circadian rythm related genes—PML—Paget's disease of bone	0.00236	0.00515	CbGpPWpGaD
Ruxolitinib—MAP3K7—TGF-beta receptor signaling—PML—Paget's disease of bone	0.00234	0.00513	CbGpPWpGaD
Ruxolitinib—JAK1—p73 transcription factor network—PML—Paget's disease of bone	0.00234	0.00513	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling events mediated by PTP1B—CSF1—Paget's disease of bone	0.00233	0.0051	CbGpPWpGaD
Ruxolitinib—JAK2—GMCSF-mediated signaling events—INPP5D—Paget's disease of bone	0.00232	0.00508	CbGpPWpGaD
Ruxolitinib—Infection—Risedronate—Paget's disease of bone	0.00231	0.00425	CcSEcCtD
Ruxolitinib—Body temperature increased—Alendronate—Paget's disease of bone	0.00229	0.00422	CcSEcCtD
Ruxolitinib—Anaemia—Zoledronate—Paget's disease of bone	0.00229	0.00421	CcSEcCtD
Ruxolitinib—Nervous system disorder—Risedronate—Paget's disease of bone	0.00228	0.0042	CcSEcCtD
Ruxolitinib—TYK2—IL-4 Signaling Pathway—INPP5D—Paget's disease of bone	0.00226	0.00495	CbGpPWpGaD
Ruxolitinib—MAP3K2—BDNF signaling pathway—ALPL—Paget's disease of bone	0.00226	0.00494	CbGpPWpGaD
Ruxolitinib—Skin disorder—Risedronate—Paget's disease of bone	0.00226	0.00416	CcSEcCtD
Ruxolitinib—MAP3K7—TNF receptor signaling pathway —SQSTM1—Paget's disease of bone	0.00224	0.0049	CbGpPWpGaD
Ruxolitinib—Infection—Pamidronate—Paget's disease of bone	0.0022	0.00404	CcSEcCtD
Ruxolitinib—PHKG2—Carbohydrate metabolism—NUP205—Paget's disease of bone	0.00218	0.00476	CbGpPWpGaD
Ruxolitinib—MAP3K3—Signaling by Interleukins—INPP5D—Paget's disease of bone	0.00217	0.00475	CbGpPWpGaD
Ruxolitinib—Nervous system disorder—Pamidronate—Paget's disease of bone	0.00217	0.00399	CcSEcCtD
Ruxolitinib—Thrombocytopenia—Pamidronate—Paget's disease of bone	0.00216	0.00398	CcSEcCtD
Ruxolitinib—Headache—Etidronic acid—Paget's disease of bone	0.00213	0.00392	CcSEcCtD
Ruxolitinib—PLK1—Integrated Breast Cancer Pathway—PML—Paget's disease of bone	0.00211	0.00462	CbGpPWpGaD
Ruxolitinib—JAK2—Interleukin-11 Signaling Pathway—BGLAP—Paget's disease of bone	0.00211	0.00461	CbGpPWpGaD
Ruxolitinib—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—Paget's disease of bone	0.00209	0.00385	CcSEcCtD
Ruxolitinib—Asthenia—Alendronate—Paget's disease of bone	0.00208	0.00383	CcSEcCtD
Ruxolitinib—IRAK1—IL-1 signaling pathway—SQSTM1—Paget's disease of bone	0.00206	0.00451	CbGpPWpGaD
Ruxolitinib—Pruritus—Alendronate—Paget's disease of bone	0.00205	0.00377	CcSEcCtD
Ruxolitinib—JAK3—Signaling by Interleukins—INPP5D—Paget's disease of bone	0.00205	0.00448	CbGpPWpGaD
Ruxolitinib—MAP3K7—TCR signaling—INPP5D—Paget's disease of bone	0.00205	0.00447	CbGpPWpGaD
Ruxolitinib—JAK2—Interleukin-3, 5 and GM-CSF signaling—INPP5D—Paget's disease of bone	0.00202	0.00442	CbGpPWpGaD
Ruxolitinib—Gastrointestinal disorder—Risedronate—Paget's disease of bone	0.00201	0.0037	CcSEcCtD
Ruxolitinib—Infection—Zoledronate—Paget's disease of bone	0.00201	0.00369	CcSEcCtD
Ruxolitinib—Fatigue—Risedronate—Paget's disease of bone	0.002	0.00369	CcSEcCtD
Ruxolitinib—JAK2—Notch-mediated HES/HEY network—BGLAP—Paget's disease of bone	0.002	0.00437	CbGpPWpGaD
Ruxolitinib—Nervous system disorder—Zoledronate—Paget's disease of bone	0.00198	0.00365	CcSEcCtD
Ruxolitinib—Thrombocytopenia—Zoledronate—Paget's disease of bone	0.00198	0.00364	CcSEcCtD
Ruxolitinib—Skin disorder—Zoledronate—Paget's disease of bone	0.00196	0.00361	CcSEcCtD
Ruxolitinib—PLK1—Regulation of toll-like receptor signaling pathway—SQSTM1—Paget's disease of bone	0.00195	0.00427	CbGpPWpGaD
Ruxolitinib—MAP3K3—Signaling by Interleukins—SQSTM1—Paget's disease of bone	0.00195	0.00426	CbGpPWpGaD
Ruxolitinib—MAP3K7—RANKL/RANK Signaling Pathway—SQSTM1—Paget's disease of bone	0.00194	0.00424	CbGpPWpGaD
Ruxolitinib—MAP3K7—IL-1 signaling pathway—SQSTM1—Paget's disease of bone	0.00194	0.00424	CbGpPWpGaD
Ruxolitinib—JAK2—Interleukin-2 signaling—INPP5D—Paget's disease of bone	0.00192	0.00419	CbGpPWpGaD
Ruxolitinib—Dizziness—Alendronate—Paget's disease of bone	0.00192	0.00353	CcSEcCtD
Ruxolitinib—Gastrointestinal disorder—Pamidronate—Paget's disease of bone	0.00191	0.00351	CcSEcCtD
Ruxolitinib—Fatigue—Pamidronate—Paget's disease of bone	0.0019	0.00351	CcSEcCtD
Ruxolitinib—DYRK1A—Cell Cycle, Mitotic—OPTN—Paget's disease of bone	0.00189	0.00414	CbGpPWpGaD
Ruxolitinib—JAK2—IL-3 Signaling Pathway—INPP5D—Paget's disease of bone	0.00185	0.00406	CbGpPWpGaD
Ruxolitinib—MAP3K7—BCR signaling pathway—INPP5D—Paget's disease of bone	0.00185	0.00404	CbGpPWpGaD
Ruxolitinib—Body temperature increased—Risedronate—Paget's disease of bone	0.00184	0.00338	CcSEcCtD
Ruxolitinib—JAK3—Signaling by Interleukins—SQSTM1—Paget's disease of bone	0.00183	0.00401	CbGpPWpGaD
Ruxolitinib—MAP3K2—EGF/EGFR Signaling Pathway—INPP5D—Paget's disease of bone	0.00182	0.00399	CbGpPWpGaD
Ruxolitinib—CAMK2G—Interferon Signaling—NUP205—Paget's disease of bone	0.00182	0.00398	CbGpPWpGaD
Ruxolitinib—Headache—Alendronate—Paget's disease of bone	0.00181	0.00334	CcSEcCtD
Ruxolitinib—MAP3K2—BDNF signaling pathway—SQSTM1—Paget's disease of bone	0.0018	0.00393	CbGpPWpGaD
Ruxolitinib—IRAK1—Apoptosis Modulation and Signaling—TNFRSF11B—Paget's disease of bone	0.00179	0.00391	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by Interleukins—INPP5D—Paget's disease of bone	0.00176	0.00385	CbGpPWpGaD
Ruxolitinib—PLK1—Integrated Pancreatic Cancer Pathway—PML—Paget's disease of bone	0.00175	0.00383	CbGpPWpGaD
Ruxolitinib—Body temperature increased—Pamidronate—Paget's disease of bone	0.00175	0.00322	CcSEcCtD
Ruxolitinib—Gastrointestinal disorder—Zoledronate—Paget's disease of bone	0.00174	0.00321	CcSEcCtD
Ruxolitinib—Fatigue—Zoledronate—Paget's disease of bone	0.00174	0.0032	CcSEcCtD
Ruxolitinib—IRAK1—p75(NTR)-mediated signaling—SQSTM1—Paget's disease of bone	0.00172	0.00376	CbGpPWpGaD
Ruxolitinib—JAK2—IL-4 Signaling Pathway—INPP5D—Paget's disease of bone	0.00172	0.00375	CbGpPWpGaD
Ruxolitinib—DYRK1A—Cell Cycle—OPTN—Paget's disease of bone	0.00169	0.0037	CbGpPWpGaD
Ruxolitinib—Asthenia—Risedronate—Paget's disease of bone	0.00167	0.00307	CcSEcCtD
Ruxolitinib—CAMK2G—Cellular responses to stress—VCP—Paget's disease of bone	0.00167	0.00365	CbGpPWpGaD
Ruxolitinib—JAK2—AGE/RAGE pathway—ALPL—Paget's disease of bone	0.00165	0.0036	CbGpPWpGaD
Ruxolitinib—Pruritus—Risedronate—Paget's disease of bone	0.00164	0.00303	CcSEcCtD
Ruxolitinib—CAMK2G—Interferon Signaling—PML—Paget's disease of bone	0.00161	0.00352	CbGpPWpGaD
Ruxolitinib—JAK2—Kit receptor signaling pathway—INPP5D—Paget's disease of bone	0.0016	0.0035	CbGpPWpGaD
Ruxolitinib—Body temperature increased—Zoledronate—Paget's disease of bone	0.0016	0.00294	CcSEcCtD
Ruxolitinib—Asthenia—Pamidronate—Paget's disease of bone	0.00159	0.00292	CcSEcCtD
Ruxolitinib—PRKCE—Myometrial Relaxation and Contraction Pathways—CALCA—Paget's disease of bone	0.00158	0.00346	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by Interleukins—SQSTM1—Paget's disease of bone	0.00158	0.00345	CbGpPWpGaD
Ruxolitinib—MAP3K3—EGF/EGFR Signaling Pathway—INPP5D—Paget's disease of bone	0.00157	0.00343	CbGpPWpGaD
Ruxolitinib—Pruritus—Pamidronate—Paget's disease of bone	0.00156	0.00288	CcSEcCtD
Ruxolitinib—Dizziness—Risedronate—Paget's disease of bone	0.00154	0.00283	CcSEcCtD
Ruxolitinib—JAK2—IL4-mediated signaling events—INPP5D—Paget's disease of bone	0.00154	0.00336	CbGpPWpGaD
Ruxolitinib—ROCK1—TGF-beta Signaling Pathway—PML—Paget's disease of bone	0.00153	0.00335	CbGpPWpGaD
Ruxolitinib—IRAK1—p75 NTR receptor-mediated signalling—SQSTM1—Paget's disease of bone	0.0015	0.00327	CbGpPWpGaD
Ruxolitinib—JAK2—Interferon gamma signaling—PML—Paget's disease of bone	0.00146	0.0032	CbGpPWpGaD
Ruxolitinib—Dizziness—Pamidronate—Paget's disease of bone	0.00146	0.00269	CcSEcCtD
Ruxolitinib—Headache—Risedronate—Paget's disease of bone	0.00146	0.00268	CcSEcCtD
Ruxolitinib—CAMK2G—Myometrial Relaxation and Contraction Pathways—CALCA—Paget's disease of bone	0.00145	0.00317	CbGpPWpGaD
Ruxolitinib—Asthenia—Zoledronate—Paget's disease of bone	0.00145	0.00267	CcSEcCtD
Ruxolitinib—JAK1—Interferon Signaling—NUP205—Paget's disease of bone	0.00144	0.00316	CbGpPWpGaD
Ruxolitinib—Pruritus—Zoledronate—Paget's disease of bone	0.00143	0.00263	CcSEcCtD
Ruxolitinib—PLK1—M Phase—NUP205—Paget's disease of bone	0.0014	0.00306	CbGpPWpGaD
Ruxolitinib—JAK1—Integrated Breast Cancer Pathway—PML—Paget's disease of bone	0.0014	0.00305	CbGpPWpGaD
Ruxolitinib—Headache—Pamidronate—Paget's disease of bone	0.00138	0.00255	CcSEcCtD
Ruxolitinib—MAP3K7—B Cell Receptor Signaling Pathway—INPP5D—Paget's disease of bone	0.00137	0.00301	CbGpPWpGaD
Ruxolitinib—PLK1—Cell Cycle, Mitotic—OPTN—Paget's disease of bone	0.00135	0.00295	CbGpPWpGaD
Ruxolitinib—DYRK1A—Cell Cycle, Mitotic—NUP205—Paget's disease of bone	0.00134	0.00294	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling by Interleukins—INPP5D—Paget's disease of bone	0.00134	0.00293	CbGpPWpGaD
Ruxolitinib—Dizziness—Zoledronate—Paget's disease of bone	0.00133	0.00246	CcSEcCtD
Ruxolitinib—TYK2—Signaling by Interleukins—INPP5D—Paget's disease of bone	0.0013	0.00284	CbGpPWpGaD
Ruxolitinib—PLK1—Mitotic M-M/G1 phases—NUP205—Paget's disease of bone	0.00128	0.0028	CbGpPWpGaD
Ruxolitinib—PRKG2—Hemostasis—INPP5D—Paget's disease of bone	0.00128	0.00279	CbGpPWpGaD
Ruxolitinib—JAK1—Interferon Signaling—PML—Paget's disease of bone	0.00128	0.00279	CbGpPWpGaD
Ruxolitinib—JAK1—EGF/EGFR Signaling Pathway—INPP5D—Paget's disease of bone	0.00127	0.00279	CbGpPWpGaD
Ruxolitinib—Headache—Zoledronate—Paget's disease of bone	0.00126	0.00233	CcSEcCtD
Ruxolitinib—MAP3K7—Signaling by Interleukins—INPP5D—Paget's disease of bone	0.00126	0.00276	CbGpPWpGaD
Ruxolitinib—PLK4—Cell Cycle, Mitotic—OPTN—Paget's disease of bone	0.00126	0.00275	CbGpPWpGaD
Ruxolitinib—ROCK1—EGF/EGFR Signaling Pathway—INPP5D—Paget's disease of bone	0.00125	0.00274	CbGpPWpGaD
Ruxolitinib—CAMK2G—Cytokine Signaling in Immune system—NUP205—Paget's disease of bone	0.00122	0.00266	CbGpPWpGaD
Ruxolitinib—PLK1—Cell Cycle—OPTN—Paget's disease of bone	0.00121	0.00264	CbGpPWpGaD
Ruxolitinib—JAK2—CXCR4-mediated signaling events—INPP5D—Paget's disease of bone	0.0012	0.00264	CbGpPWpGaD
Ruxolitinib—DYRK1A—Cell Cycle—NUP205—Paget's disease of bone	0.0012	0.00263	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling by Interleukins—SQSTM1—Paget's disease of bone	0.0012	0.00263	CbGpPWpGaD
Ruxolitinib—MAP3K3—Cytokine Signaling in Immune system—NUP205—Paget's disease of bone	0.00119	0.0026	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by Interleukins—SQSTM1—Paget's disease of bone	0.00117	0.00255	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling by Interleukins—SQSTM1—Paget's disease of bone	0.00113	0.00247	CbGpPWpGaD
Ruxolitinib—PLK4—Cell Cycle—OPTN—Paget's disease of bone	0.00112	0.00246	CbGpPWpGaD
Ruxolitinib—JAK3—Cytokine Signaling in Immune system—NUP205—Paget's disease of bone	0.00112	0.00245	CbGpPWpGaD
Ruxolitinib—MAP3K7—TGF-beta Signaling Pathway—PML—Paget's disease of bone	0.00111	0.00244	CbGpPWpGaD
Ruxolitinib—CAMK2G—Cytokine Signaling in Immune system—PML—Paget's disease of bone	0.00107	0.00235	CbGpPWpGaD
Ruxolitinib—TYK2—Interferon Signaling—NUP205—Paget's disease of bone	0.00107	0.00233	CbGpPWpGaD
Ruxolitinib—MAP3K3—Cytokine Signaling in Immune system—PML—Paget's disease of bone	0.00105	0.0023	CbGpPWpGaD
Ruxolitinib—CAMK2G—Cytokine Signaling in Immune system—INPP5D—Paget's disease of bone	0.00104	0.00227	CbGpPWpGaD
Ruxolitinib—MAP3K3—Cytokine Signaling in Immune system—INPP5D—Paget's disease of bone	0.00101	0.00222	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling by NGF—SQSTM1—Paget's disease of bone	0.000998	0.00218	CbGpPWpGaD
Ruxolitinib—JAK3—Cytokine Signaling in Immune system—PML—Paget's disease of bone	0.00099	0.00217	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by Interleukins—INPP5D—Paget's disease of bone	0.000985	0.00216	CbGpPWpGaD
Ruxolitinib—IRAK1—Regulation of toll-like receptor signaling pathway—SQSTM1—Paget's disease of bone	0.000981	0.00215	CbGpPWpGaD
Ruxolitinib—JAK1—Cytokine Signaling in Immune system—NUP205—Paget's disease of bone	0.000964	0.00211	CbGpPWpGaD
Ruxolitinib—PLK1—Cell Cycle, Mitotic—NUP205—Paget's disease of bone	0.000958	0.0021	CbGpPWpGaD
Ruxolitinib—JAK3—Cytokine Signaling in Immune system—INPP5D—Paget's disease of bone	0.000955	0.00209	CbGpPWpGaD
Ruxolitinib—TYK2—Interferon Signaling—PML—Paget's disease of bone	0.000942	0.00206	CbGpPWpGaD
Ruxolitinib—CAMK2G—Cytokine Signaling in Immune system—SQSTM1—Paget's disease of bone	0.000929	0.00203	CbGpPWpGaD
Ruxolitinib—MAP3K7—Regulation of toll-like receptor signaling pathway—SQSTM1—Paget's disease of bone	0.000924	0.00202	CbGpPWpGaD
Ruxolitinib—MAP3K3—Cytokine Signaling in Immune system—SQSTM1—Paget's disease of bone	0.000908	0.00199	CbGpPWpGaD
Ruxolitinib—PLK4—Cell Cycle, Mitotic—NUP205—Paget's disease of bone	0.000893	0.00195	CbGpPWpGaD
Ruxolitinib—GRK1—Disease—VCP—Paget's disease of bone	0.000892	0.00195	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by Interleukins—SQSTM1—Paget's disease of bone	0.000883	0.00193	CbGpPWpGaD
Ruxolitinib—JAK2—BDNF signaling pathway—ALPL—Paget's disease of bone	0.000881	0.00193	CbGpPWpGaD
Ruxolitinib—PLK1—Cell Cycle—NUP205—Paget's disease of bone	0.000856	0.00187	CbGpPWpGaD
Ruxolitinib—JAK3—Cytokine Signaling in Immune system—SQSTM1—Paget's disease of bone	0.000856	0.00187	CbGpPWpGaD
Ruxolitinib—JAK1—Cytokine Signaling in Immune system—PML—Paget's disease of bone	0.000852	0.00186	CbGpPWpGaD
Ruxolitinib—JAK1—Cytokine Signaling in Immune system—INPP5D—Paget's disease of bone	0.000822	0.0018	CbGpPWpGaD
Ruxolitinib—JAK2—Interferon Signaling—NUP205—Paget's disease of bone	0.000807	0.00177	CbGpPWpGaD
Ruxolitinib—PHKG2—Disease—VCP—Paget's disease of bone	0.000807	0.00177	CbGpPWpGaD
Ruxolitinib—PLK4—Cell Cycle—NUP205—Paget's disease of bone	0.000799	0.00175	CbGpPWpGaD
Ruxolitinib—HIPK2—Gene Expression—NUP205—Paget's disease of bone	0.000781	0.00171	CbGpPWpGaD
Ruxolitinib—JAK1—Cytokine Signaling in Immune system—SQSTM1—Paget's disease of bone	0.000737	0.00161	CbGpPWpGaD
Ruxolitinib—IRAK1—Cytokine Signaling in Immune system—NUP205—Paget's disease of bone	0.000733	0.0016	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by NGF—SQSTM1—Paget's disease of bone	0.000724	0.00158	CbGpPWpGaD
Ruxolitinib—JAK2—Interferon Signaling—PML—Paget's disease of bone	0.000714	0.00156	CbGpPWpGaD
Ruxolitinib—JAK2—EGF/EGFR Signaling Pathway—INPP5D—Paget's disease of bone	0.000712	0.00156	CbGpPWpGaD
Ruxolitinib—TYK2—Cytokine Signaling in Immune system—NUP205—Paget's disease of bone	0.000711	0.00156	CbGpPWpGaD
Ruxolitinib—PRKCE—Hemostasis—INPP5D—Paget's disease of bone	0.000705	0.00154	CbGpPWpGaD
Ruxolitinib—JAK2—BDNF signaling pathway—SQSTM1—Paget's disease of bone	0.000702	0.00154	CbGpPWpGaD
Ruxolitinib—MAP3K7—Cytokine Signaling in Immune system—NUP205—Paget's disease of bone	0.00069	0.00151	CbGpPWpGaD
Ruxolitinib—GRK1—Disease—NUP205—Paget's disease of bone	0.000682	0.00149	CbGpPWpGaD
Ruxolitinib—PRKG2—Signaling Pathways—VCP—Paget's disease of bone	0.000664	0.00145	CbGpPWpGaD
Ruxolitinib—IRAK1—Cytokine Signaling in Immune system—PML—Paget's disease of bone	0.000648	0.00142	CbGpPWpGaD
Ruxolitinib—TYK2—Cytokine Signaling in Immune system—PML—Paget's disease of bone	0.000629	0.00138	CbGpPWpGaD
Ruxolitinib—IRAK1—Cytokine Signaling in Immune system—INPP5D—Paget's disease of bone	0.000625	0.00137	CbGpPWpGaD
Ruxolitinib—GRK1—Signaling Pathways—VCP—Paget's disease of bone	0.000625	0.00137	CbGpPWpGaD
Ruxolitinib—PHKG2—Disease—NUP205—Paget's disease of bone	0.000617	0.00135	CbGpPWpGaD
Ruxolitinib—MAP3K7—Cytokine Signaling in Immune system—PML—Paget's disease of bone	0.00061	0.00133	CbGpPWpGaD
Ruxolitinib—PRKG2—Metabolism—NUP205—Paget's disease of bone	0.000607	0.00133	CbGpPWpGaD
Ruxolitinib—TYK2—Cytokine Signaling in Immune system—INPP5D—Paget's disease of bone	0.000607	0.00133	CbGpPWpGaD
Ruxolitinib—JAK3—Hemostasis—INPP5D—Paget's disease of bone	0.000595	0.0013	CbGpPWpGaD
Ruxolitinib—MAP3K7—Cytokine Signaling in Immune system—INPP5D—Paget's disease of bone	0.000588	0.00129	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—VCP—Paget's disease of bone	0.000565	0.00124	CbGpPWpGaD
Ruxolitinib—IRAK1—Cytokine Signaling in Immune system—SQSTM1—Paget's disease of bone	0.00056	0.00123	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling by NGF—SQSTM1—Paget's disease of bone	0.000551	0.00121	CbGpPWpGaD
Ruxolitinib—TYK2—Cytokine Signaling in Immune system—SQSTM1—Paget's disease of bone	0.000544	0.00119	CbGpPWpGaD
Ruxolitinib—JAK2—Cytokine Signaling in Immune system—NUP205—Paget's disease of bone	0.000539	0.00118	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by NGF—SQSTM1—Paget's disease of bone	0.000535	0.00117	CbGpPWpGaD
Ruxolitinib—MAP3K7—Cytokine Signaling in Immune system—SQSTM1—Paget's disease of bone	0.000527	0.00115	CbGpPWpGaD
Ruxolitinib—PRKCE—Disease—VCP—Paget's disease of bone	0.000524	0.00115	CbGpPWpGaD
Ruxolitinib—PRKG2—Metabolism—INPP5D—Paget's disease of bone	0.000518	0.00113	CbGpPWpGaD
Ruxolitinib—PHKG2—Metabolism—NUP205—Paget's disease of bone	0.000516	0.00113	CbGpPWpGaD
Ruxolitinib—JAK1—Hemostasis—INPP5D—Paget's disease of bone	0.000512	0.00112	CbGpPWpGaD
Ruxolitinib—GRK1—Disease—CALCA—Paget's disease of bone	0.000506	0.00111	CbGpPWpGaD
Ruxolitinib—JAK2—Cytokine Signaling in Immune system—PML—Paget's disease of bone	0.000477	0.00104	CbGpPWpGaD
Ruxolitinib—JAK2—Cytokine Signaling in Immune system—INPP5D—Paget's disease of bone	0.00046	0.00101	CbGpPWpGaD
Ruxolitinib—PHKG2—Disease—CALCA—Paget's disease of bone	0.000458	0.001	CbGpPWpGaD
Ruxolitinib—PHKG2—Metabolism—INPP5D—Paget's disease of bone	0.00044	0.000963	CbGpPWpGaD
Ruxolitinib—PRKCE—Immune System—NUP205—Paget's disease of bone	0.000434	0.000949	CbGpPWpGaD
Ruxolitinib—JAK2—Cytokine Signaling in Immune system—SQSTM1—Paget's disease of bone	0.000412	0.000902	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by NGF—SQSTM1—Paget's disease of bone	0.000405	0.000887	CbGpPWpGaD
Ruxolitinib—PRKCE—Disease—NUP205—Paget's disease of bone	0.0004	0.000876	CbGpPWpGaD
Ruxolitinib—CAMK2G—Immune System—NUP205—Paget's disease of bone	0.000397	0.000869	CbGpPWpGaD
Ruxolitinib—PRKG2—Signaling Pathways—SQSTM1—Paget's disease of bone	0.000388	0.000849	CbGpPWpGaD
Ruxolitinib—MAP3K3—Immune System—NUP205—Paget's disease of bone	0.000388	0.000849	CbGpPWpGaD
Ruxolitinib—PRKCE—GPCR downstream signaling—CALCA—Paget's disease of bone	0.000388	0.000849	CbGpPWpGaD
Ruxolitinib—PRKCE—Immune System—PML—Paget's disease of bone	0.000383	0.000838	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—VCP—Paget's disease of bone	0.00038	0.000832	CbGpPWpGaD
Ruxolitinib—PRKG2—Signaling Pathways—CALCA—Paget's disease of bone	0.000377	0.000825	CbGpPWpGaD
Ruxolitinib—PRKCE—Immune System—INPP5D—Paget's disease of bone	0.00037	0.000809	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—VCP—Paget's disease of bone	0.000367	0.000802	CbGpPWpGaD
Ruxolitinib—JAK3—Immune System—NUP205—Paget's disease of bone	0.000366	0.000801	CbGpPWpGaD
Ruxolitinib—GRK1—Signaling Pathways—SQSTM1—Paget's disease of bone	0.000365	0.000798	CbGpPWpGaD
Ruxolitinib—GRK1—Signaling Pathways—CALCA—Paget's disease of bone	0.000354	0.000775	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling by GPCR—CALCA—Paget's disease of bone	0.000352	0.000771	CbGpPWpGaD
Ruxolitinib—CAMK2G—Immune System—PML—Paget's disease of bone	0.000351	0.000768	CbGpPWpGaD
Ruxolitinib—MAP3K3—Immune System—PML—Paget's disease of bone	0.000343	0.00075	CbGpPWpGaD
Ruxolitinib—CAMK2G—Immune System—INPP5D—Paget's disease of bone	0.000339	0.000741	CbGpPWpGaD
Ruxolitinib—PRKCE—Immune System—SQSTM1—Paget's disease of bone	0.000331	0.000725	CbGpPWpGaD
Ruxolitinib—MAP3K3—Immune System—INPP5D—Paget's disease of bone	0.000331	0.000724	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—SQSTM1—Paget's disease of bone	0.00033	0.000722	CbGpPWpGaD
Ruxolitinib—JAK3—GPCR downstream signaling—CALCA—Paget's disease of bone	0.000327	0.000716	CbGpPWpGaD
Ruxolitinib—JAK3—Immune System—PML—Paget's disease of bone	0.000323	0.000708	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—CALCA—Paget's disease of bone	0.00032	0.000701	CbGpPWpGaD
Ruxolitinib—MAP3K7—Adaptive Immune System—INPP5D—Paget's disease of bone	0.000317	0.000693	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—NUP205—Paget's disease of bone	0.000315	0.000689	CbGpPWpGaD
Ruxolitinib—JAK3—Immune System—INPP5D—Paget's disease of bone	0.000312	0.000683	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—VCP—Paget's disease of bone	0.00031	0.000677	CbGpPWpGaD
Ruxolitinib—CAMK2G—Immune System—SQSTM1—Paget's disease of bone	0.000304	0.000664	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling by GPCR—CALCA—Paget's disease of bone	0.000297	0.00065	CbGpPWpGaD
Ruxolitinib—PRKCE—Disease—CALCA—Paget's disease of bone	0.000297	0.00065	CbGpPWpGaD
Ruxolitinib—MAP3K3—Immune System—SQSTM1—Paget's disease of bone	0.000296	0.000649	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—NUP205—Paget's disease of bone	0.000291	0.000636	CbGpPWpGaD
Ruxolitinib—JAK2—Hemostasis—INPP5D—Paget's disease of bone	0.000286	0.000627	CbGpPWpGaD
Ruxolitinib—JAK1—GPCR downstream signaling—CALCA—Paget's disease of bone	0.000282	0.000616	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—VCP—Paget's disease of bone	0.000281	0.000614	CbGpPWpGaD
Ruxolitinib—JAK3—Immune System—SQSTM1—Paget's disease of bone	0.00028	0.000612	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—PML—Paget's disease of bone	0.000278	0.000609	CbGpPWpGaD
Ruxolitinib—ROCK1—GPCR downstream signaling—CALCA—Paget's disease of bone	0.000277	0.000606	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—INPP5D—Paget's disease of bone	0.000268	0.000587	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—VCP—Paget's disease of bone	0.000266	0.000583	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—VCP—Paget's disease of bone	0.000262	0.000573	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by GPCR—CALCA—Paget's disease of bone	0.000256	0.00056	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling by GPCR—CALCA—Paget's disease of bone	0.000252	0.00055	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—SQSTM1—Paget's disease of bone	0.000241	0.000526	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—NUP205—Paget's disease of bone	0.000239	0.000524	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—NUP205—Paget's disease of bone	0.000232	0.000508	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—NUP205—Paget's disease of bone	0.000225	0.000493	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—CALCA—Paget's disease of bone	0.000216	0.000472	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—NUP205—Paget's disease of bone	0.000215	0.000469	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—SQSTM1—Paget's disease of bone	0.000214	0.000469	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—VCP—Paget's disease of bone	0.000213	0.000465	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—PML—Paget's disease of bone	0.000212	0.000463	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—CALCA—Paget's disease of bone	0.000208	0.000455	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—PML—Paget's disease of bone	0.000205	0.000449	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—INPP5D—Paget's disease of bone	0.000204	0.000447	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—VCP—Paget's disease of bone	0.000202	0.000443	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—PML—Paget's disease of bone	0.000199	0.000436	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—INPP5D—Paget's disease of bone	0.000198	0.000434	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—VCP—Paget's disease of bone	0.000197	0.00043	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—INPP5D—Paget's disease of bone	0.000192	0.00042	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—VCP—Paget's disease of bone	0.000191	0.000417	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by GPCR—CALCA—Paget's disease of bone	0.000189	0.000413	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—SQSTM1—Paget's disease of bone	0.000183	0.0004	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—SQSTM1—Paget's disease of bone	0.000181	0.000396	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—SQSTM1—Paget's disease of bone	0.000178	0.000389	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—NUP205—Paget's disease of bone	0.000176	0.000385	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—CALCA—Paget's disease of bone	0.000176	0.000384	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—SQSTM1—Paget's disease of bone	0.000172	0.000377	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—NUP205—Paget's disease of bone	0.000163	0.000356	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—CALCA—Paget's disease of bone	0.000159	0.000348	CbGpPWpGaD
Ruxolitinib—JAK2—GPCR downstream signaling—CALCA—Paget's disease of bone	0.000158	0.000345	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—PML—Paget's disease of bone	0.000156	0.000341	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—SQSTM1—Paget's disease of bone	0.000156	0.00034	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—SQSTM1—Paget's disease of bone	0.000153	0.000335	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—CALCA—Paget's disease of bone	0.000151	0.000331	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—INPP5D—Paget's disease of bone	0.00015	0.000329	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—VCP—Paget's disease of bone	0.000149	0.000326	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—CALCA—Paget's disease of bone	0.000149	0.000325	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—CALCA—Paget's disease of bone	0.000143	0.000313	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—SQSTM1—Paget's disease of bone	0.000135	0.000295	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—CALCA—Paget's disease of bone	0.000121	0.000264	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—SQSTM1—Paget's disease of bone	0.000118	0.000259	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—CALCA—Paget's disease of bone	0.000115	0.000251	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—SQSTM1—Paget's disease of bone	0.000115	0.000251	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—CALCA—Paget's disease of bone	0.000112	0.000244	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—SQSTM1—Paget's disease of bone	0.000111	0.000244	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—CALCA—Paget's disease of bone	0.000108	0.000237	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—SQSTM1—Paget's disease of bone	8.7e-05	0.00019	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—CALCA—Paget's disease of bone	8.45e-05	0.000185	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—NUP205—Paget's disease of bone	3.85e-05	8.42e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—INPP5D—Paget's disease of bone	3.28e-05	7.18e-05	CbGpPWpGaD
